Literature DB >> 23775719

Trends in blood transfusion among hospitalized children with sickle cell disease.

Jean L Raphael1, Suzette O Oyeku, Marc A Kowalkowski, Brigitta U Mueller, Angela M Ellison.   

Abstract

BACKGROUND: Blood transfusions represent a major therapeutic option in acute management of sickle cell disease (SCD). Few data exist documenting trends in transfusion among children with SCD, particularly during hospitalization. PROCEDURE: This was an analysis of cross-sectional data of hospital discharges within the Kid's Inpatient Database (years 1997, 2000, 2003, 2006, 2009). Hospitalizations for children (0-18 years) with a primary or secondary SCD-related diagnosis were examined. The primary outcome was blood transfusion. Trends in transfusion were assessed using weighted multivariate logistic regression in a merged dataset with year as the primary independent variable. Co-variables consisted of child and hospital characteristics. Multivariate logistic regression was conducted for 2009 data to assess child and hospital-level factors associated with transfusion.
RESULTS: From 1997 to 2009, the percentage of SCD-related hospitalizations with transfusion increased from 14.2% to 28.8% (P < 0.0001). Among all SCD-related hospitalizations, the odds of transfusion increased over 20% for each successive study interval. Hospitalizations with vaso-occlusive pain crisis (OR 1.35, 95% CI 1.27-1.43) or acute chest syndrome/pneumonia (OR 1.24, 95% CI 1.13-1.35) as the primary diagnoses had the highest odds of transfusion for each consecutive study interval. Older age and male gender were associated with higher odds of transfusion.
CONCLUSIONS: Blood transfusion is increasing over time among hospitalized children with SCD. Further study is warranted to identify indications contributing to the rise in transfusions and if transfusions in the inpatient setting have been used appropriately. Future studies should also assess the impact of rising trends on morbidity, mortality, and other health-related outcomes.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; health care utilization; outcomes research; sickle cell disease

Mesh:

Year:  2013        PMID: 23775719      PMCID: PMC4091906          DOI: 10.1002/pbc.24630

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  35 in total

1.  Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years.

Authors:  Emma Drasar; Norris Igbineweka; Nisha Vasavda; Matthew Free; Moji Awogbade; Marlene Allman; Aleksandar Mijovic; Swee Lay Thein
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

Review 2.  Indications and complications of transfusions in sickle cell disease.

Authors:  Kim Smith-Whitley; Alexis A Thompson
Journal:  Pediatr Blood Cancer       Date:  2012-05-04       Impact factor: 3.167

Review 3.  Challenges of alloimmunization in patients with haemoglobinopathies.

Authors:  Stella T Chou; Robert I Liem; Alexis A Thompson
Journal:  Br J Haematol       Date:  2012-10-04       Impact factor: 6.998

Review 4.  A review of acute chest syndrome in pediatric sickle cell disease.

Authors:  Hussein A Abbas; Mario Kahale; Maen Aboul Hosn; Adlette Inati
Journal:  Pediatr Ann       Date:  2013-03       Impact factor: 1.132

Review 5.  Indications for red cell transfusion in sickle cell disease.

Authors:  K Ohene-Frempong
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

6.  Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.

Authors:  S K Ballas
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

7.  Financial analysis of chronic transfusion for stroke prevention in sickle cell disease.

Authors:  A S Wayne; S E Schoenike; C H Pegelow
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

Review 8.  How I treat acute chest syndrome in children with sickle cell disease.

Authors:  Scott T Miller
Journal:  Blood       Date:  2011-03-15       Impact factor: 22.113

9.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

10.  National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2012-11-14       Impact factor: 3.167

View more
  6 in total

1.  Complications of sickle cell anaemia in children in Northwestern Tanzania.

Authors:  Hamza Saidi; Luke R Smart; Erasmus Kamugisha; Emmanuela E Ambrose; Deogratias Soka; Robert N Peck; Julie Makani
Journal:  Hematology       Date:  2016-02-17       Impact factor: 2.269

Review 2.  Sickle cell disease: when and how to transfuse.

Authors:  Jo Howard
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.

Authors:  Jean L Raphael; Troy Richardson; Matt Hall; Suzette O Oyeku; David G Bundy; Ram V Kalpatthi; Samir S Shah; Angela M Ellison
Journal:  J Pediatr       Date:  2015-10-23       Impact factor: 4.406

4.  Blood Transfusion Frequency and Indications in Yemeni Children with Sickle Cell Disease.

Authors:  Abdul-Wahab M Al-Saqladi; Dikra M Maddi; Aida H Al-Sadeeq
Journal:  Anemia       Date:  2020-08-24

5.  "A child with sickle cell disease can't live with just anyone." A mixed methods study of socio-behavioral influences and severity of sickle cell disease in northern Nigeria.

Authors:  Zubairu Iliyasu; Awwal M Borodo; Binta W Jibir; Nafisa S Nass; Muktar H Aliyu
Journal:  Health Sci Rep       Date:  2020-12-23

6.  Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study.

Authors:  Janet L Kwiatkowski; Mona Hamdy; Amal El-Beshlawy; Fatma S E Ebeid; Mohammed Badr; Abdulrahman Alshehri; Julie Kanter; Baba Inusa; Amira A M Adly; Suzan Williams; Yurdanur Kilinc; David Lee; Fernando Tricta; Mohsen S Elalfy
Journal:  Blood Adv       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.